Short answer
Oscar Health, Inc. (OSCR) filed an 8-K current report with the SEC on November 16, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Board expanded from 8 to 11 directors with appointments of Tomer Cohen, Eric Larsen, and Rajat Taneja effective November 13, 2026.
Oscar Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board expanded from 8 to 11 directors with appointments of Tomer Cohen, Eric Larsen, and Rajat Taneja effective November 13, 2026
- Independent directors add product, healthcare, private-equity, AI, cybersecurity, and global technology expertise
- Committee coverage strengthened: Cohen joins Compensation, Taneja joins Audit and Nominating and Corporate Governance
- Director compensation includes $70,000 annual board retainers, committee fees, and $200,000 initial and annual RSU grants
- Eric Larsen’s senior-advisor role at Thrive Capital, Oscar’s majority stockholder, creates a relevant governance relationship despite NYSE independence designation
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Oscar Health, Inc. 8-K filings
Get the next OSCR 8-K as it lands
Follow OSCR for push alerts, or ask the research agent what this filing means.